Based on recent data, Zura Bio Limited (ZURA) shows an Average True Range (ATR) of 0.5 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 666.22K, indicating liquidity. These fundamental metrics provide insight into ZURA's underlying financial health and market activity.
| ATR | 0.5 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 666.22K |
| Avg Vol (10 Days) | 434.55K |
Zura Bio Limited (ZURA) technical indicators as of March 19, 2026: the SMA 20 is 8.72%, SMA 50 at 21.66%, and SMA 200 at 114.89%. The RSI 14 value is 62.37, suggesting its current momentum. These technical analysis signals help assess ZURA's price trends and potential future movements.
| SMA 20 | 8.72% |
| SMA 50 | 21.66% |
| SMA 200 | 114.89% |
| RSI 14 | 62.37 |
Zura Bio Limited (ZURA) stock performance overview as of March 19, 2026: The 52-week high is $7.44 (currently -5.84% below), and the 52-week low is $0.97 (currently 597.94% above). Over the past year, ZURA's performance is 178.33%, compared to the S&P 500's 17.63% change.
| 52-Week High | 7.44 |
| 52-Week High Chg | -5.84% |
| 52-Week Low | 0.97 |
| 52-Week Low Chg | +597.94% |
| S&P 500 52-Week Chg | 17.63% |
According to market data, Zura Bio Limited (ZURA) stock's recent performance metrics show that over the last month, ZURA is 17.06%, with a Year-to-Date (YTD) performance of -4.39%. Over the past year, the stock has seen a 178.33% change. These figures summarize ZURA's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 7.04 | 7.44 | 7.44 | 7.44 | 7.44 | 7.44 |
| Low | 5.9 | 5.78 | 3.69 | 1.88 | 0.97 | 4.36 |
| Performance | -2.91% | +17.06% | +56.07% | +191.28% | +178.33% | -4.39% |
According to current financial data, ZURA stock's P/E (TTM) ratio is -9.16, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ZURA, including P/S (N/A), P/B (5.29), and P/FCF (-7.36), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ZURA | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -9.16 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 5.29 | 58.95 | 5.21 | 4.58 |
| P/FCF (TTM) | -7.36 | 48.38 | -197.65 | 31.85 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep